Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2025 07:00 ET | Source: Belharra Therapeutics, Inc.

Belharra Therapeutics Announces Appointment of Sean Buchanan, Ph.D., as Chief Scientific Officer and Retirement of Gary O’Neill, Ph.D.

Belharra Therapeutics announces appointment of Sean Buchanan, Ph.D., as Chief Scientific Officer and retirement of Gary O’Neill, Ph.D.
June 18, 2024 07:00 ET | Source: Belharra Therapeutics, Inc.

Belharra Therapeutics Announces Strategic Collaboration with Sanofi to Advance Discovery of Novel Small Molecule Therapeutics for Immunological Diseases

Belharra today announced a strategic collaboration with Sanofi to advance the discovery of novel small molecule therapeutics for immunological diseases.